SEC Company Response from Beyond Air, Inc. (XAIR) (CIK 0001641631) (XAIR) — May 24, 2017
Beyond Air, Inc. (XAIR) (CIK 0001641631)
Date: May 24, 2017 · CIK: 0001641631 · Accession: 0001178913-17-001593
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-216287
Letter
AIT Therapeutics, Inc.
2 Ilan Ramon, Science Park
Ness Ziona, 7403635 Israel
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Andri Carpenter
Gary Todd
Heather Percival
Geoff Kruczek
Amanda Ravitz
Re: AIT Therapeutics, Inc.
Registration Statement on Form S-1, as amended
File No. 333-216287
Ladies and Gentlemen:
AIT Therapeutics, Inc., a Delaware corporation (the "Company"), hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (as amended, the "Registration Statement") so that such Registration Statement shall become effective at 4:00 p.m. (Washington, D.C. time) on Friday, May 26, 2017 or as soon thereafter as practicable.
Please provide a copy of the Commission's order declaring the Registration Statement effective to Amir Avniel at the address first set forth above.
Respectfully yours,
AIT Therapeutics, Inc.
Show Raw Text
CORRESP 1 filename1.htm AIT Therapeutics, Inc. 2 Ilan Ramon, Science Park Ness Ziona, 7403635 Israel VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Andri Carpenter Gary Todd Heather Percival Geoff Kruczek Amanda Ravitz Re: AIT Therapeutics, Inc. Registration Statement on Form S-1, as amended File No. 333-216287 Ladies and Gentlemen: AIT Therapeutics, Inc., a Delaware corporation (the "Company"), hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (as amended, the "Registration Statement") so that such Registration Statement shall become effective at 4:00 p.m. (Washington, D.C. time) on Friday, May 26, 2017 or as soon thereafter as practicable. Please provide a copy of the Commission's order declaring the Registration Statement effective to Amir Avniel at the address first set forth above. Respectfully yours, AIT Therapeutics, Inc. By: /s/ Amir Avniel Amir Avniel President, Chief Executive Officer, and Director